PharmDr. Martin Čulen, Ph.D.
Assistant professor, Department of Internal Medicine, Hematology and Oncology
correspondence Address:
Jihlavská 340/20, 625 00 Brno
office: bldg. F01B2/156
Kamenice 126/3
625 00 Brno
phone: | +420 532 23 4641 |
---|---|
e‑mail: |
social and academic networks: |
---|
Total number of publications: 67
2023
-
Inhibition of acute myeloid leukemia using palbociclib and ponatinib in a patient-derived xenograft model.
Year: 2023, type: Conference abstract
-
Povrchové markery leukemických kmenových buněk u chronické myeloidní leukemie
Transfuze a hematologie dnes, year: 2023, volume: 29, edition: 1, DOI
2022
-
. Drug repurposing for venetoclax-resistant acute myeloid leukemia.
Year: 2022, type: Conference abstract
-
BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in Ph+ chronic myeloid leukemia
American Journal of Hematology, year: 2022, volume: 97, edition: 9, DOI
-
Genome-wide Screening Optimizations and High-throughput Compound Screening to Identify Novel Treatment Options in Venetoclax-resistant AML
Year: 2022, type: Conference abstract
-
Identification of novel therapeutic options for venetoclax-resistant AML cells through drug repurposing
Year: 2022, type: Conference abstract
-
Prediction of novel treatment options for CLL and AML cells based on drug repurposing.
Year: 2022, type: Conference abstract
-
Prediction of novel treatment options for venetoclax-resistant AML cells based on drug repurposing.
Year: 2022, type: Conference abstract
-
Selected Analytical Techniques of Solid State, Structure Identification, and Dissolution Testing in Drug Life Cycle. Analytical Techniques in Drug Life Cycle
Year: 2022, type: Editorship of scientific publication
2021
-
Acute myeloid leukemia regression induced by palbociclib and ponatinib in patient –derived xenograft model.
Year: 2021, type: Conference abstract